Blood Transfusion After Percutaneous Coronary Intervention and Risk of Subsequent Adverse Outcomes

被引:57
作者
Kwok, Chun Shing [1 ]
Sherwood, Matthew W. [2 ]
Watson, Sarah M. [3 ]
Nasir, Samina B. [3 ]
Sperrin, Matt [4 ]
Nolan, Jim [5 ]
Kinnaird, Tim [6 ]
Kiatchoosakun, Songsak [7 ]
Ludman, Peter F. [8 ]
de Belder, Mark A. [9 ]
Rao, Sunil V. [2 ]
Mamas, Mamas A. [1 ]
机构
[1] Univ Manchester, Cardiovasc Inst, Manchester M13 9WL, Lancs, England
[2] Duke Clin Res Inst, Durham, NC USA
[3] Royal Bolton Hosp, Dept Gastroenterol, Farnworth, Lancs, England
[4] Univ Manchester, Inst Populat Hlth, Manchester M13 9WL, Lancs, England
[5] Univ Hosp North Staffordshire, Dept Cardiol, Stoke On Trent, Staffs, England
[6] Univ Wales Hosp, Dept Cardiol, Cardiff CF4 4XW, S Glam, Wales
[7] Khon Kaen Univ, Dept Med, Khon Kaen, Thailand
[8] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2TH, W Midlands, England
[9] James Cook Univ Hosp, Dept Cardiol, Middlesbrough, Cleveland, England
基金
英国医学研究理事会;
关键词
blood transfusion; cardiovascular events; meta-analysis; mortality; ACUTE MYOCARDIAL-INFARCTION; ARTERIAL ACCESS SITE; LONG-TERM SURVIVAL; CELL TRANSFUSION; PROGNOSTIC IMPLICATIONS; PRIMARY ANGIOPLASTY; INCREASED MORTALITY; CLINICAL-PRACTICE; IMPACT; ANEMIA;
D O I
10.1016/j.jcin.2014.09.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to define the prevalence and prognostic impact of blood transfusions in contemporary percutaneous coronary intervention (PCI) practice. BACKGROUND Although the presence of anemia is associated with adverse outcomes in patients undergoing PCI, the optimal use of blood products in patients undergoing PCI remains controversial. METHODS A search of EMBASE and MEDLINE was conducted to identify PCI studies that evaluated blood transfusions and their association withmajor adverse cardiac events (MACE) andmortality. Two independent reviewers screened the studies for inclusion, and data were extracted from relevant studies. Random effects meta-analysis was used to estimate the risk of adverse outcomes with blood transfusions. Statistical heterogeneity was assessed by considering the I-2 statistic. RESULTS Nineteen studies that included 2,258,711 patients with more than 54,000 transfusion events were identified (prevalence of blood transfusion 2.3%). Crude mortality rate was 6,435 of 50,979 (12.6%, 8 studies) in patients who received a blood transfusion and 27,061 of 2,266,111 (1.2%, 8 studies) in the remaining patients. Crude MACE rates were 17.4% (8,439 of 48,518) in patients who had a blood transfusion and 3.1% (68,062 of 2,212,730) in the remaining cohort. Meta-analysis demonstrated that blood transfusion was independently associated with an increase in mortality (odds ratio: 3.02, 95% confidence interval: 2.16 to 4.21, I-2 = 91%) and MACE (odds ratio: 3.15, 95% confidence interval: 2.59 to 3.82, I-2 = 81%). Similar observations were recorded in studies that adjusted for baseline hematocrit, anemia, and bleeding. CONCLUSIONS Blood transfusion is independently associated with increased risk of mortality and MACE events. Clinicians should minimize the risk for periprocedural transfusion by using available bleeding-avoidance strategies and avoiding liberal transfusion practices. (C) 2015 by the American College of Cardiology Foundation.
引用
收藏
页码:436 / 446
页数:11
相关论文
共 43 条
  • [1] [Anonymous], CATHETER CARDIOVASC
  • [2] Relation of Periprocedural Bleeding Complications and Long-Term Outcome in Patients Undergoing Percutaneous Coronary Revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)
    Brugts, Jasper Jan
    Mercado, Nestor
    Hu, Stephen
    Guarneri, Mimi
    Price, Matthew
    Schatz, Richard
    Teirstein, Paul
    Wijns, William
    Serruys, Patrick W.
    O'Neill, William W.
    Boersma, Eric
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (07) : 917 - 922
  • [3] Body Mass Index, Periprocedural Bleeding, and Outcome Following Percutaneous Coronary Intervention (from the British Columbia Cardiac Registry)
    Byrne, Jonathan
    Spence, Mark S.
    Fretz, Eric
    Mildenberger, Richard
    Chase, Alex
    Berry, Brian
    Pi, David
    Janssen, Christian
    Klinke, Peter
    Hilton, David
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (04) : 507 - 511
  • [4] Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease
    Carson, Jeffrey L.
    Brooks, Maria Mori
    Abbott, J. Dawn
    Chaitman, Bernard
    Kelsey, Sheryl F.
    Triulzi, Darrell J.
    Srinivas, Vankeepuram
    Menegus, Mark A.
    Marroquin, Oscar C.
    Rao, Sunil V.
    Noveck, Helaine
    Passano, Elizabeth
    Hardison, Regina M.
    Smitherman, Thomas
    Vagaonescu, Tudor
    Wimmer, Neil J.
    Williams, David O.
    [J]. AMERICAN HEART JOURNAL, 2013, 165 (06) : 964 - +
  • [5] Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB
    Carson, Jeffrey L.
    Grossman, Brenda J.
    Kleinman, Steven
    Tinmouth, Alan T.
    Marques, Marisa B.
    Fung, Mark K.
    Holcomb, John B.
    Illoh, Orieji
    Kaplan, Lewis J.
    Katz, Louis M.
    Rao, Sunil V.
    Roback, John D.
    Shander, Aryeh
    Tobian, Aaron A. R.
    Weinstein, Robert
    McLaughlin, Lisa Grace Swinton
    Djulbegovic, Benjamin
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (01) : 49 - U95
  • [6] Association of the arterial access site at angioplasty with transfusion and mortality: the MORTAL study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)
    Chase, A. J.
    Fretz, E. B.
    Warburton, W. P.
    Klinke, W. P.
    Carere, R. G.
    Pi, D.
    Berry, B.
    Hilton, J. D.
    [J]. HEART, 2008, 94 (08) : 1019 - 1025
  • [7] Association of Blood Transfusion With Increased Mortality in Myocardial Infarction A Meta-analysis and Diversity-Adjusted Study Sequential Analysis
    Chatterjee, Saurav
    Wetterslev, Jorn
    Sharma, Abhishek
    Lichstein, Edgar
    Mukherjee, Debabrata
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (02) : 132 - 139
  • [8] Dada MR, 2009, J AM COLL CARDIOL, V53, pA379
  • [9] When can odds ratios mislead?
    Davies, HTO
    Crombie, IK
    Tavakoli, M
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7136) : 989 - 991
  • [10] Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention Implications for Contemporary Practice
    Doyle, Brendan J.
    Rihal, Charanjit S.
    Gastineau, Dennis A.
    Holmes, David R., Jr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (22) : 2019 - 2027